Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China IND Requirements Overly Burdensome To Industry - Shanghai R&D Summit

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The pharmaceutical industry should lobby the Chinese government to relax requirements for IND approvals that discourage multinational companies from sponsoring clinical trials in China, according to Hutchison MediPharma Managing Director Samantha Du

You may also be interested in...



Generics History Hobbles Trial Work In China

NEW YORK - Fast, unpredictable change in fragmented China - where companies face retention and regulatory challenges despite in many cases being revenue-generating - brings risk as well as possibility

Generics History Hobbles Trial Work In China

NEW YORK - Fast, unpredictable change in fragmented China - where companies face retention and regulatory challenges despite in many cases being revenue-generating - brings risk as well as possibility

Merck KGaA Looks To Chinese Medicine For Oncology Candidates

Collaboration with China’s Chi-Med is part of an initiative to strengthen Merck’s natural compound expertise, exec tells “The Pink Sheet” DAILY.

UsernamePublicRestriction

Register

ID017698

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel